Relationship between Inhaled Corticosteroid Therapy and Rate of Lung Function Decline in Children with Cystic Fibrosis
Authors:
- David J. PastaDPDavid J. Pasta
- Lawrence RasouliyanLRLawrence Rasouliyan
- Jeffrey S. WagenerJWJeffrey S. Wagener
- Michael W. KonstanMKMichael W. Konstan
- Wayne J. MorganWMWayne J. Morgan
- 1 December 2008
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 153 (6) , 746-751.e2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- High-Dose Ibuprofen in Cystic Fibrosis: Canadian Safety and Effectiveness TrialThe Journal of Pediatrics, 2007
- Inflammation and Anti-Inflammatory Therapies for Cystic FibrosisClinics in Chest Medicine, 2007
- Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: A pilot study†‡Pediatric Pulmonology, 2001
- The Use of Anti-inflammatory Medications in Cystic FibrosisChest, 1999
- Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic Bronchopulmonary Pseudomonas aeruginosa InfectionAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosisThe Journal of Pediatrics, 1996
- A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosisThe Journal of Pediatrics, 1995
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Inhaled Glucocorticoids for AsthmaNew England Journal of Medicine, 1995
- The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosisRespiratory Medicine, 1995